Bottles of Similac baby formula from Abbott Laboratories are visible in a shipment box, in Lafayette, California, May 13, 2022. Shortages of baby formula were reported in early 2022.
(Smith Collection/Gado/Getty Images) WASHINGTON - Abbott Laboratories is under investigation by the Food and Drug Administration (FDA) following a recent report of another baby’s death potentially connected to Abbott formula. The baby died in January after consuming Abbott formula, and the FDA said in a release Wednesday they learned about the child’s death from a June 10 consumer complaint. The agency did not say which Abbott formula the child consumed or if it was connected to the Abbott Laboratories plant shutdown in February. "The agency has initiated an investigation, given that the complaint referenced that the infant had consumed an Abbott product.
However, the investigation of this most recent consumer complaint is in its preliminary stages and the agency will provide an update as it learns more," the FDA said in a statement.RELATED: Abbott's baby formula plant reopens: How long before parents see more supply?According to the FDA, officials have reported complaints connected to nine infant deaths. Two of those deaths were linked to the Abbott Nutrition Sturgis plant investigation.
But the agency did not definitively say whether or not there is a link between the infant deaths and the formula manufactured at Abbott Nutrition’s Sturgis plant in Michigan.Approximately 129 complaints were reviewed involving the Abbott formula, the FDA shared. The agency explains that 119 of those complaints were reported after Abbott voluntarily recalled their formula products on Feb.
death
reports
Provident